<?xml version='1.0' encoding='utf-8'?>
<document id="31337333"><sentence text="Drug repurposing with network reinforcement." /><sentence text="Drug repurposing has been motivated to ameliorate low probability of success in drug discovery" /><sentence text=" For the recent decade, many in silico attempts have received primary attention as a first step to alleviate the high cost and longevity" /><sentence text=" Such study has taken benefits of abundance, variety, and easy accessibility of pharmaceutical and biomedical data" /><sentence text=" Utilizing the research friendly environment, in this study, we propose a network-based machine learning algorithm for drug repurposing" /><sentence text=" Particularly, we show a framework on how to construct a drug network, and how to strengthen the network by employing multiple/heterogeneous types of data" /><sentence text="" /><sentence text="The proposed method consists of three steps" /><sentence text=" First, we construct a drug network from drug-target protein information" /><sentence text=" Then, the drug network is reinforced by utilizing drug-drug interaction knowledge on bioactivity and/or medication from literature databases" /><sentence text=" Through the enhancement, the number of connected nodes and the number of edges between them become more abundant and informative, which can lead to a higher probability of success of in silico drug repurposing" /><sentence text=" The enhanced network recommends candidate drugs for repurposing through drug scoring" /><sentence text=" The scoring process utilizes graph-based semi-supervised learning to determine the priority of recommendations" /><sentence text="" /><sentence text="The drug network is reinforced in terms of the coverage and connections of drugs: the drug coverage increases from 4738 to 5442, and the drug-drug associations as well from 808,752 to 982,361" /><sentence text=" Along with the network enhancement, drug recommendation becomes more reliable: AUC of 0" /><sentence text="89 was achieved lifted from 0" /><sentence text="79" /><sentence text=" For typical cases, 11 recommended drugs were shown for vascular dementia: amantadine, conotoxin GV, tenocyclidine, cycloeucine, etc"><entity charOffset="75-85" id="DDI-PubMed.31337333.s19.e0" text="amantadine" /><entity charOffset="87-99" id="DDI-PubMed.31337333.s19.e1" text="conotoxin GV" /><entity charOffset="101-114" id="DDI-PubMed.31337333.s19.e2" text="tenocyclidine" /><entity charOffset="116-127" id="DDI-PubMed.31337333.s19.e3" text="cycloeucine" /><pair ddi="false" e1="DDI-PubMed.31337333.s19.e0" e2="DDI-PubMed.31337333.s19.e0" /><pair ddi="false" e1="DDI-PubMed.31337333.s19.e0" e2="DDI-PubMed.31337333.s19.e1" /><pair ddi="false" e1="DDI-PubMed.31337333.s19.e0" e2="DDI-PubMed.31337333.s19.e2" /><pair ddi="false" e1="DDI-PubMed.31337333.s19.e0" e2="DDI-PubMed.31337333.s19.e3" /><pair ddi="false" e1="DDI-PubMed.31337333.s19.e1" e2="DDI-PubMed.31337333.s19.e1" /><pair ddi="false" e1="DDI-PubMed.31337333.s19.e1" e2="DDI-PubMed.31337333.s19.e2" /><pair ddi="false" e1="DDI-PubMed.31337333.s19.e1" e2="DDI-PubMed.31337333.s19.e3" /><pair ddi="false" e1="DDI-PubMed.31337333.s19.e2" e2="DDI-PubMed.31337333.s19.e2" /><pair ddi="false" e1="DDI-PubMed.31337333.s19.e2" e2="DDI-PubMed.31337333.s19.e3" /></sentence><sentence text="" /></document>